The delivered artifact

Release readiness, written down

Two candidates from the same team on the same product. The difference between them is not how many defects were found, it is how much the methods agreed with each other. One of these blocks the release and the other clears it.

🔴unknown / release-readinessBlockedRC1
Residual defect estimate exceeds budget
methods           Static analysis (46), Manual review (44), Fuzzing (50)
pairwise overlap  11, 19, 9
distinct found    104
estimated total   175   [89 to 336]
estimated left    71
coverage          59%   gate 90%
budget            3 estimated remaining
verdict           KEEP TESTING

Found 104 of an estimated 175, so roughly 71 are still in there. The gate is 90% coverage and this run is at 59%.

Assumptions this verdict rests on
  • The 3 methods above are treated as independent. If any two of them share a rule set, a checklist, or a reviewer, the overlap is inflated and the coverage figure is too high.
  • Defects are treated as equally findable. They are not. Defects that are hard for every method never enter the overlap, so this estimate is a floor and the true remaining count is usually worse.
  • This does not say the product is unsafe. It says the testing done so far cannot support a claim that it is finished.
🟢unknown / release-readinessClearedRC2
Residual defect estimate is inside budget
methods           Static analysis (26), Manual review (26), Fuzzing (21)
pairwise overlap  16, 14, 13
distinct found    40
estimated total   41   [33 to 50]
estimated left    1
coverage          97%   gate 90%
budget            3 estimated remaining
verdict           SHIP

Every pair of methods overlapped heavily, so the population is well covered. Found 40 of an estimated 41, about 1 still out there against a budget of 3.

Assumptions this verdict rests on
  • The 3 methods above are treated as independent. If any two of them share a rule set, a checklist, or a reviewer, the overlap is inflated and the coverage figure is too high.
  • Defects are treated as equally findable. They are not. Defects that are hard for every method never enter the overlap, so this estimate is a floor and the true remaining count is usually worse.
  • This clears a stated residual budget. It is not a statement that the product is defect-free, and nothing here can be.
The half that is worth paying for

Anyone can write a gate that blocks on open criticals. What nobody currently produces is the first card: 104 findings, all triaged, all fixed, and a defensible statement that roughly 71 are still in there. Without that number the honest answer to “are we done” is a shrug, and the release goes out on whoever is most tired of arguing.